Union Bancaire Privee UBP SA Purchases Shares of 55,396 UnitedHealth Group Incorporated (NYSE:UNH)

Union Bancaire Privee UBP SA bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 55,396 shares of the healthcare conglomerate’s stock, valued at approximately $27,233,000.

Several other large investors have also bought and sold shares of the stock. Capital Asset Advisory Services LLC boosted its holdings in UnitedHealth Group by 11.5% during the fourth quarter. Capital Asset Advisory Services LLC now owns 7,343 shares of the healthcare conglomerate’s stock worth $3,767,000 after purchasing an additional 760 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of UnitedHealth Group by 34.4% in the fourth quarter. Blue Trust Inc. now owns 14,013 shares of the healthcare conglomerate’s stock valued at $7,089,000 after acquiring an additional 3,584 shares in the last quarter. Drive Wealth Management LLC lifted its holdings in UnitedHealth Group by 4.6% during the fourth quarter. Drive Wealth Management LLC now owns 3,068 shares of the healthcare conglomerate’s stock worth $1,552,000 after acquiring an additional 135 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its position in shares of UnitedHealth Group by 2.0% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 6,916 shares of the healthcare conglomerate’s stock valued at $3,498,000 after purchasing an additional 133 shares during the last quarter. Finally, Novare Capital Management LLC grew its position in UnitedHealth Group by 1.0% during the fourth quarter. Novare Capital Management LLC now owns 46,688 shares of the healthcare conglomerate’s stock valued at $23,618,000 after buying an additional 451 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

UNH has been the subject of several research reports. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft raised their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Bank of America dropped their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Finally, Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Stock Up 0.5 %

Shares of NYSE UNH opened at $532.26 on Monday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The stock has a market capitalization of $489.83 billion, a P/E ratio of 34.34, a PEG ratio of 1.41 and a beta of 0.62. The firm’s 50 day simple moving average is $541.04 and its two-hundred day simple moving average is $564.34. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the company earned $5.83 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.58%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.